Germany's PharmaSGP Raises Sales Guidance In 'Record Year'
European Consumer health player PharmaSGP is well on the way to achieving new record revenues in 2022, and is working to maintain this upward trajectory over the medium and long term.
You may also be interested in...
Supply problems for Nestlé’s US dietary supplement brands “were more fundamental than initially we have estimated,” according to CEO Mark Schneider. Nestlé now expects the issue – first flagged up last year – won’t be fully resolved until the end of the first half of 2024.
Ibuprofen generic sold by Spain's Liconsa should have its marketing authorization suspended in multiple EU member states as it is not bioequivalent to reference product Nurofen Rapid, rules the European Medicines Agency.
The European Safety Authority is running consultations on its proposals to set safe intake levels from foods, including dietary supplements, for iron and vitamin A.